Michael G. Kauffman M.D., Ph.D.
Net Worth

Last updated:

What is Michael G. Kauffman M.D., Ph.D. net worth?

The estimated net worth of Dr. Michael G. Kauffman M.D., Ph.D. is at least $30,660,081 as of 28 Feb 2022. He owns shares worth $4,425,293 as insider, has earned $15,386,038 from insider trading and has received compensation worth at least $10,848,750 in Karyopharm Therapeutics Inc..

What is the salary of Michael G. Kauffman M.D., Ph.D.?

Dr. Michael G. Kauffman M.D., Ph.D. salary is $986,250 per year as Co-Founder, Senior Clinical Advisor & Director in Karyopharm Therapeutics Inc..

How old is Michael G. Kauffman M.D., Ph.D.?

Dr. Michael G. Kauffman M.D., Ph.D. is 62 years old, born in 1963.

What stocks does Michael G. Kauffman M.D., Ph.D. currently own?

As insider, Dr. Michael G. Kauffman M.D., Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Karyopharm Therapeutics Inc. (KPTI) Co-Founder, Senior Clinical Advisor & Director 713,757 $6.2 $4,425,293

What does Karyopharm Therapeutics Inc. do?

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma, and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company has license agreement with Menarini Group to develop and commercialize NEXPOVIO for human oncology indications in Europe, including the United Kingdom; Latin America; and other countries. Its oral SINE compounds also designed to force nuclear accumulation in the levels of multiple tumor suppressor and growth regulatory proteins. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.

Michael G. Kauffman M.D., Ph.D. insider trading

Karyopharm Therapeutics Inc.

Dr. Michael G. Kauffman M.D., Ph.D. has made 69 insider trades between 2014-2022, according to the Form 4 filled with the SEC. Most recently he sold 6,226 units of KPTI stock worth $63,742 on 28 Feb 2022.

The largest trade he's ever made was exercising 200,000 units of KPTI stock on 2 Jul 2014. As of 28 Feb 2022 he still owns at least 713,757 units of KPTI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 6,226 $10.24 $63,742
Sale
Common Stock 6,226 $10.24 $63,742
Sale
Common Stock 9,088 $12.12 $110,174
Sale
Common Stock 9,079 $12.12 $110,065
Sale
Common Stock 6,764 $9.86 $66,707
Sale
Common Stock 6,707 $9.86 $66,144
Sale
Common Stock 4,000 $12.39 $49,552
Sale
Common Stock 18,990 $14.83 $281,641
Sale
Common Stock 18,990 $14.83 $281,641
Option
Restricted Stock Units 21,800 N/A N/A
Option
Common Stock 43,600 N/A N/A
Option
Common Stock 43,600 N/A N/A
Sale
Common Stock 13,243 $15.52 $205,518
Sale
Common Stock 13,243 $15.52 $205,518
Option
Common Stock 28,600 N/A N/A
Option
Restricted Stock Units 14,300 N/A N/A
Option
Stock Option (right to buy) 1,424 $0.03 $47
Sale
Common Stock 7,500 $14.89 $111,683
Option
Common Stock 7,500 $0.03 $248
Option
Stock Option (right to buy) 1,477 $0.03 $49
Option
Common Stock 1,477 $0.03 $49
Sale
Common Stock 1,477 $0.03 $49
Sale
Common Stock 7,500 $0.03 $248
Option
Stock Option (right to buy) 7,500 $0.03 $248
Option
Common Stock 7,500 $0.03 $248
Option
Common Stock 7,500 $4.75 $35,640
Option
Stock Option (right to buy) 7,500 $4.75 $35,640
Sale
Common Stock 7,500 $19.34 $145,058
Option
Common Stock 7,500 $4.75 $35,640
Sale
Common Stock 7,500 $4.75 $35,640
Option
Stock Option (right to buy) 7,500 $4.75 $35,640
Sale
Common Stock 7,500 $0.03 $248
Option
Common Stock 7,500 $0.03 $248
Option
Stock Option (right to buy) 7,500 $0.03 $248
Option
Common Stock 7,500 $8.12 $60,878
Option
Stock Option (right to buy) 7,500 $8.12 $60,878
Sale
Common Stock 7,143 $0.03 $236
Option
Stock Option (right to buy) 7,500 $4.75 $35,640
Sale
Common Stock 7,500 $4.75 $35,640
Option
Common Stock 7,500 $4.75 $35,640
Option
Stock Option (right to buy) 7,500 $4.75 $35,640
Sale
Common Stock 7,500 $4.75 $35,640
Option
Common Stock 7,500 $4.75 $35,640
Sale
Common Stock 7,500 $0.03 $248
Option
Stock Option (right to buy) 7,500 $0.03 $248
Option
Common Stock 7,500 $0.03 $248
Option
Stock Option (right to buy) 7,500 $0.03 $248
Sale
Common Stock 7,500 $0.03 $248
Option
Common Stock 7,500 $0.03 $248
Option
Common Stock 15,000 $4.75 $71,280
Option
Stock Option (right to buy) 15,000 $4.75 $71,280
Sale
Common Stock 15,000 $4.75 $71,280
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $22.38 $223,750
Option
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $22.48 $224,800
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Sale
Common Stock 17,634 $16.48 $290,644
Option
Restricted Stock Units 21,800 N/A N/A
Option
Common Stock 43,600 N/A N/A
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Option
Common Stock 20,000 $4.75 $95,040
Sale
Common Stock 20,000 $4.75 $95,040
Option
Stock Option (right to buy) 20,000 $4.75 $95,040
Option
Common Stock 20,000 $4.75 $95,040
Option
Stock Option (right to buy) 20,000 $4.75 $95,040
Sale
Common Stock 20,000 $4.75 $95,040
Option
Common Stock 12,500 $0.03 $413
Sale
Common Stock 12,500 $0.03 $413
Option
Stock Option (right to buy) 12,500 $0.03 $413
Option
Stock Option (right to buy) 12,500 $0.03 $413
Option
Common Stock 12,500 $0.03 $413
Sale
Common Stock 12,500 $0.03 $413
Option
Common Stock 9,600 $4.75 $45,619
Option
Stock Option (right to buy) 9,600 $4.75 $45,619
Sale
Common Stock 9,600 $4.75 $45,619
Option
Common Stock 400 $4.75 $1,901
Sale
Common Stock 400 $4.75 $1,901
Option
Stock Option (right to buy) 400 $4.75 $1,901
Option
Stock Option (right to buy) 12,500 $0.03 $413
Sale
Common Stock 12,500 $0.03 $413
Option
Common Stock 12,500 $0.03 $413
Option
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 12,500 $0.03 $413
Sale
Common Stock 12,500 $15.76 $197,013
Option
Common Stock 12,500 $0.03 $413
Sale
Common Stock 10,000 $4.75 $47,520
Option
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 12,500 $0.03 $413
Option
Common Stock 12,500 $0.03 $413
Sale
Common Stock 12,500 $0.03 $413
Option
Common Stock 10,000 $4.75 $47,520
Sale
Common Stock 10,000 $4.75 $47,520
Option
Stock Option (right to buy) 10,000 $4.75 $47,520
Option
Common Stock 12,500 $0.03 $413
Sale
Common Stock 12,500 $0.03 $413
Option
Stock Option (right to buy) 12,500 $0.03 $413
Sale
Common Stock 10,000 $18.27 $182,690
Option
Common Stock 10,000 $1.68 $16,830
Option
Stock Option (right to buy) 4,243 $2.39 $10,153
Option
Stock Option (right to buy) 1 $0.03 $0
Sale
Common Stock 12,500 $0.03 $413
Option
Common Stock 12,500 $0.03 $413
Option
Stock Option (right to buy) 12,500 $0.03 $413
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Sale
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.15 $1,490
Option
Stock Option (right to buy) 10,000 $0.15 $1,490
Sale
Common Stock 10,000 $17.3 $172,990
Sale
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Sale
Common Stock 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.13 $1,320
Sale
Common Stock 10,000 $14.79 $147,880
Option
Common Stock 10,000 $14.79 $147,880
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Sale
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Sale
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $16.15 $161,460
Sale
Common Stock 10,000 $16.15 $161,460
Option
Stock Option (right to buy) 10,000 $0.13 $1,320
Sale
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Sale
Common Stock 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Sale
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Sale
Common Stock 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Sale
Common Stock 10,000 $0.26 $2,640
Sale
Common Stock 10,000 $0.26 $2,640
Option
Stock Option (right to buy) 10,000 $0.26 $2,640
Option
Common Stock 10,000 $0.26 $2,640
Sale
Common Stock 50,000 $33 $1,650,000
Sale
Common Stock 200,000 $42.5 $8,500,000
Sale
Common Stock 10,000 $40.36 $403,640
Sale
Common Stock 10,000 $40.36 $403,640

Karyopharm Therapeutics key executives

Karyopharm Therapeutics Inc. executives and other stock owners filed with the SEC:

  • Dr. Mansoor Raza Mirza (64) Clinical Consultant, Member of Scientific Advisory Board & Director
  • Dr. Michael G. Kauffman M.D., Ph.D. (62) Co-Founder, Senior Clinical Advisor & Director
  • Dr. Sharon Shacham (55) Co-Founder, Chief Scientific Officer & Chairman of Scientific Advisory Board
  • Mr. Michael P. Mason CPA, M.B.A. (50) Senior Vice President, Chief Financial Officer & Treasurer
  • Mr. Richard A. Paulson M.B.A. (58) Pres, Chief Executive Officer & Director